Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : HDT Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
MalarVx licenses HDT Bio's repRNA/LION™ Technology for Novel Malaria Vaccine
Details : Under the license agreement, MalarVx grants HDT access to the epRNA and LION platforms to support malaria vaccine formulation.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
January 16, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : HDT Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement